Global Coronary Stents Market Worth US $9.5 Billion by 2016 Forecasts a New Research Report at

Share Article

"Coronary Stents – Global Trends, Estimates, and Forecasts 2012-2018" and "Coronary Stents – Emerging Markets (Brazil, Russia, India, China, South Africa, and South Korea) 2012-2018" are new market research reports added to the store.

More than 727 market players are identified in cardiovascular devices industry, out of which 122 key companies that project improved market activities in the near future are profiled.

Past News Releases


Global Coronary Stents sector is projected to reach US$9.5 billion by 2016. North America accounts for nearly 41% (2015) of the global value, while Europe claims approximately 29% (2018). Asia-Pacific is the fastest growing region with a CAGR of 8.8%, driving a market value of US$1.5 billion by 2015. On a global scale, projections for drug eluting stents market share indicate more than 40% by 2015, leaving the rest of the market to the bare metal stents and other devices. By Coating, Polymer stent coating segment is the fastest growing market with a CAGR of 8.7% for analysis period 2012-2018.

More than 727 market players are identified in cardiovascular devices industry, out of which, 122 key companies that project improved market activities in the near future are profiled. The report consists of 222 data charts describing the market shares, sales forecasts, and growth prospects. Moreover, key strategic activities in the market, including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Key Companies Profiled in “Coronary Stents – Global Trends, Estimates, and Forecasts, 2012-2018:”

North America
Alere, Inc., Cardiorobotics, Inc., Interface Biologics, Inc., Meridian Health System, Inc, Cardiva Medical, Inc., Lombard Medical Technologies Plc, Deltex Medical Group Plc, Biotelemetry, Inc., Bioheart, Inc Asahi Intecc Co., Ltd., Angiodynamics, Inc., Merit Medical Systems, Inc., Molecular Devices, Llc, Accellent, Inc., Medtronic, Inc., Abbott Vascular Devices, Cambridge Heart, Inc., Greatbatch, Inc. , Abiomed, Inc., Advansource Biomaterials Corporation and more.

Berlin Heart Gmbh, Esaote S.P.A, Sophion Bioscience A/S, Biotronik Gmbh & Co. Kg., Dräger Medical Ag & Co. Kg, Bioteque Corporation, Spectranetics International B.V, Aortech International, Plc., Apc Cardiovascular, Ltd., Arterial Remodeling Technologies, Ge Healthcare, Lidco Group Plc, Philips Medical Systems, Smith & Nephew Plc, Vascular Concepts, Ambu A/S, Fleming Medical Limited, Covidien Plc.

Nihon Kohden Corporation, All Pro Corporation, Fukuda Denshi Co., Ltd., Sichuan Jinjiang Electronic Science And Technology Co., Ltd, Syncardia Systems, Inc., Microports Medical, Lepu Medical, Beijing Anzhen Hospital, Fudan University Zhongshan Hospital, Indraprastha Apollo Hospital, Sahajanand Medical Technologies Pvt.,Ltd., Opto Circuits India Limited, Asahi Kasei Corporation, Asian Heart Institute, Narayana Hrudayalaya, Uscome Limited, Heartware Ltd. and more.

Purchase report directly at:

Rest of World
Inspiremd Ltd., Itgi Medical Ltd., Medinol, Ltd., Gamida Cell Ltd., Aerotel Medical Systems, Ltd.

The report primarily focuses on:

  • Emerging Market Trends
  • Advancements in the Technological Space
  • Market Demand of the Segments (By-Region)
  • Key Growth Areas and Market Size
  • Region-Wise Demand Factor
  • Key Competitors Edge
  • Investment Strategies

The analysis primarily deals with by type & stent coating. Further, the subdivided categories include:

Coronary Stents – By Type & Stent Coating

  • By Type

a. Drug-Eluting Stents (DES)
b. Bare Metal Stents (BMS)
c. Absorbable Stents/Biodegradable Metallic Stent
d. Anti-Restenosis Devices
i. Bioactive Stent
ii. Radioactive Stent
iii. Drug-Eluting Balloon

  • By Stent Coating

a. Inorganic (PERSE, Gold, Silicon Carbide, Iridium Oxide, Carbon, Titanium-Nitride-Oxide)
b. Polymer (Biodegradable & Non-Biodegradable)
c. Non-Polymer (Microporous, Microstructured, Slotted Tubular, Nanoporous, Nanopatterned)
d. Other Coatings (Heparin, Hyaluronic Acid, Fibrin), Technologies & R&D

Inquire for discount at:

The period considered for the coronary stents market analysis is 2012-2018. The region-wise distribution of the market consists of North America (USA and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Belgium and rest of Europe), Asia-Pacific (Japan, China, India, New Zealand, South Korea, Australia, and rest of Asia-Pacific)), Latin America (Brazil, Argentina, and rest of Latin America) and rest of world (South Africa, Middle East, and rest of world). The market growth rate in the major economies such as the U.S., Japan, China, etc. are estimated individually.

Country Specific Analysis for Coronary Stents:

Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa, and South Korea), 2012-2018:

BRICSS Coronary Stents market value is expected to reach US$1 billion by 2016, primarily supported by the product types - Drug Eluting Stents, Bare Metal Stents, Absorbable Stents, etc. China accounts for nearly 28% of the market share, and India claims more than 23%. In terms of CAGR, India is the fastest growing region, while China and South Korea are just behind. Among the product types, Drug Eluting Stents account nearly half of the market value, while Absorbable Stents segments indicate a close 15%. In case of Stent Coating, Polymer depicts the largest CAGR, while Non-Polymer and Inorganic in second and third place, respectively.

Purchase report directly at:

Browse other new reports by Axis Research Mind at:

About Us: is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Call +1 888 391 5441 with your industry research requirements or email the details on sales at

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
since: 06/2010
Follow >
Like >
Follow us on
Visit website